A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
Incyte Corporation
Incyte Corporation
DEKA Biosciences
Celldex Therapeutics
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano